DEN160006 is an FDA 510(k) submission (not cleared) for the everlinQ endoAVF System. Classified as Percutaneous Catheter For Creation Of An Arteriovenous Fistula For Hemodialysis Access (product code PQK), Class II - Special Controls.
Submitted by Tva Medical, Inc. (Austin, US). The FDA issued a Not Cleared (DENG) decision on June 22, 2018 after a review of 870 days.
This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1252 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway requires demonstration of substantial equivalence to a legally marketed predicate device - a standard the FDA determined was not met in this submission.
Device pattern: Regulatory edge-case submission. High predicate equivalence gap. With 870 days under review and no clearance granted, this submission reflects a case where the FDA could not confirm sufficient predicate equivalence - often indicating either a novel device category or unresolved safety and performance questions.
View all Tva Medical, Inc. devices